StockData

ABVC BioPharma vs Scienture

ABVC and SCNX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ABVC and SCNX compare

Scienture is the larger company, worth 4.5 times as much as ABVC BioPharma ($113M against $25.1M).

Scienture scores higher on the StockData Score (3 against 2 for ABVC BioPharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricABVCSCNX
Size and price
Market cap$25.1M$113M
Share price$0.940$2.76
Change, 1 year−66.4%−82.8%
Change, 5 years−97.1%−99.8%
Beta (5Y)1.721.19
Employees198
StockData Score
Total score23 (better)
Valuation score01 (better)
Growth score00
Performance score01 (better)
Health score2 (better)1
Dividend score00
Valuation
P/B2.4×1.8× (better)
Growth
Revenue growth, 5Y average−9.3% (better)−52.1%
Profitability
Return on equity−82.2%−53.5% (better)
Return on invested capital−60.6%−47.3% (better)
Financial health
Debt / equity0.01–
Interest coverage−42.0×−13.1× (better)
Current ratio0.073.04 (better)
Altman Z-score−5.040.07 (better)
Piotroski F-score5 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions4.1%–
Held by insiders0.49%16.6%
Short interest, % of float–0.34%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.